-

ORPEA: Changes in Shareholders’ Holdings

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News:

The ORPEA Group (Paris:ORP), a world leader in long-term care (nursing homes, post-acute and rehabilitation hospitals, psychiatric hospitals, and home care services), announce its new shareholding structure as of 22nd of January 2020 following the sale of Dr Marian stake.

Changes in ORPEA shareholding structure

 

31.12.20191

22.01.2020

 

Number of shares

% capital

Number of shares

% capital

CPPIB

9,374,186

14.5%

9,374,186

14.5%

Dr. Marian

4,080,420

6.3%

0

0.0%

FFP Invest

3,261,353

5.0%

3,261,353

5.0%

Sofina SA

1,298,000

2.0%

1,298,000

2.0%

Treasury shares

45,142

0.1%

45,1421

0.1%

Free Float

46,556,736

72.1%

50,637,156

78.4%

TOTAL

64,615,837

100.0%

64,615,837

100.0%

The transfer of ownership of Dr Marian’s entire stake was carried out through Accelerated Book Building on 21 January 2020.

This transaction, relating to 4,080,420 shares, i.e. 6.3% of the share capital, was carried out at a price of €111.85 per share, i.e. at a discount of 4.6% compared with the closing price on 21 January 2020.

The success of this operation was due to a steady profitable growth strategy focused on long-term value creation applied by ORPEA’s teams for the past 30 years.

This transaction increases the free float and the shareholder base and thus improves the share’s liquidity.

ORPEA would like to thank both the new and existing investors who took part in this investment. The Group would like to take this opportunity to reiterate with extreme confidence its growth strategy to reinforce its position as a world leader in long-term care which ensures its profitable growth over the short, medium and long term.

Upcoming press release: full-year 2019 revenue
11 February 2020 after market close

About ORPEA (www.orpea-corp.com)

Founded in 1989, ORPEA is one of the major world leaders in long-term care, with a network of 951 facilities comprising 96,677 beds (17,388 of which are under construction) across 16 countries, which are divided into five clusters:

  • France Benelux: 484 facilities/42,625 beds (of which 4,514 are under construction)
  • Central Europe: 238 facilities/25,419 beds (of which 4,389 are under construction)
  • Eastern Europe: 125 facilities/12,917 beds (of which 2,817 are under construction)
  • Iberian Peninsula/Latin America: 103 facilities/15,576 beds (of which 5,668 are under construction)
  • Rest of the world: 1 facility/140 beds

ORPEA is listed on Euronext Paris (ISIN code: FR0000184798) and a constituent of the SBF 120, STOXX 600 Europe, MSCI Small Cap Europe and CAC Mid 60 indices.

1 Based on information included on the list of registered shareholders at 31.12.19

Contacts

Investor Relations
ORPEA
Steve Grobet
Investor Relations Director
s.grobet@orpea.net

Hélène de Watteville
Investor Relations Officer
h.dewatteville@orpea.net

Investor Relations
NewCap
Dusan Oresansky
+33 (0)1 44 71 94 94
orpea@newcap.eu

Media Relations
Image 7
Laurence Heilbronn
+33 (0)1 53 70 74 64
lheilbronn@image7.fr

ORPEA Group

BOURSE:ORP

Release Versions

Contacts

Investor Relations
ORPEA
Steve Grobet
Investor Relations Director
s.grobet@orpea.net

Hélène de Watteville
Investor Relations Officer
h.dewatteville@orpea.net

Investor Relations
NewCap
Dusan Oresansky
+33 (0)1 44 71 94 94
orpea@newcap.eu

Media Relations
Image 7
Laurence Heilbronn
+33 (0)1 53 70 74 64
lheilbronn@image7.fr

More News From ORPEA Group

emeis: Revenue and Business Activity as of the End of March 2026

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis (Paris:EMEIS): Further increase in occupancy rates: continuation of the trend observed over the past two years The Group’s occupancy rate rose by +2.1 points to 89.1% (up +4.1 percentage points over two years), driven in particular by emeis’s efforts to further improve the quality of care and accommodations, enhance marketing processes, and offer a segmented range of services tailored to the needs of residents and patients Occupancy rate...

emeis: Availability of the 2025 Universal Registration Document

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis S.A. (Paris:EMEIS) (the “Company”) filed, on 30 April 2026, its 2025 Universal Registration Document with the French Autorité des Marchés Financiers (“AMF”). The 2025 Universal Registration Document is made available to the public under the conditions provided for by the regulations in force. It includes: the annual financial report including the 2025 management report and the Company’s individual accounts and the Group's consolidated fin...

Change to emeis’s Governance: Jean-Marc Boursier, Appointed Deputy Chief Executive Officer (Corporate Officer)

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: Jean-Marc Boursier, previously Deputy Chief Executive Officer (non board), has been appointed Deputy Chief Executive Officer (corporate officer) by the Board of Directors on 24 April 2026, following a recommendation by the Chief Executive Officer. Currently Deputy Chief Executive Officer (non board) in charge of Finance, Procurement and IT, and overseeing Central Europe and Latin America, Jean-Marc Boursier will be appointed Deputy Chief Execut...
Back to Newsroom